Development of a Novel Exosome-Based, Multiplexed RTqPCR Technology for Rapid and Accurate Detection of Circulating Tumor Acquired Resistance Variants in ESR1 at ≤0.1% Frequency

被引：0

|

作者：

Thibert, J. ^{[1
]}

Statt, S. ^{[1
]}

Chen, L. ^{[1
]}

Church, M. ^{[1
]}

Myers, J. ^{[1
]}

Yociss, M. ^{[1
]}

Hallmark, E. ^{[1
]}

Sanchez, J. ^{[2
]}

Franzen, K. ^{[2
]}

Latham, G. ^{[1
]}

Skog, J. ^{[2
]}

机构：

[1] Asuragen, Austin, TX USA

[2] Exosome Diagnost, Waltham, MA USA

来源：

JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

ST078

引用

收藏

页码：S116 / S116

页数：1

相关论文

共 3 条

[1] An exosome-based ESR1 monitoring RT-qPCR technology that rapidly and accurately detects circulating tumor acquired resistance variants at ≤0.1% frequency in liquid biopsy samples
Statt, Sarah
Thibert, Julie
Franzen, Kurt
Sanchez, Aquiles
Chen, Liangjing
Yociss, Megan
Hallmark, Elliot
Church, Melissa
Filipovic-Sadic, Stela
Latham, Gary
Skog, Johan
CANCER RESEARCH, 2023, 83 (07)
[2] An exosome-based ESR1 monitoring RT-qPCR kit that rapidly and accurately detects acquired resistance variants at ≤ 0.1% frequency in liquid biopsy samples
Statt, S.
Thibert, J. R.
Church, M.
Myers, J.
Dale, H.
Caughron, B.
Kelnar, K.
Haynes, B.
ANNALS OF ONCOLOGY, 2024, 35 : S396 - S396
[3] Multiplexed fluorescence in situ hybridization-based detection of circulating tumor cells: A novel liquid-based technology to facilitate accurate and early identification of non-small cell lung cancer patients
Zhu, Yili
Lowe, Alarice Cheng-Yi
CANCER CYTOPATHOLOGY, 2020, 128 (08) : 518 - 519